| Hematologic disorders associated with COVID-19: a review MS Rahi, V Jindal, SP Reyes, K Gunasekaran, R Gupta, I Jaiyesimi Annals of Hematology, 1-12, 2021 | 113 | 2021 |
| Cancer treatment during COVID-19 pandemic V Jindal, KK Sahu, S Gaikazian, AD Siddiqui, I Jaiyesimi Medical Oncology 37, 1-3, 2020 | 88 | 2020 |
| Interconnection between brain and retinal neurodegenerations V Jindal Molecular neurobiology 51 (3), 885-892, 2015 | 72 | 2015 |
| Neurodegeneration as a primary change and role of neuroprotection in diabetic retinopathy V Jindal Molecular neurobiology 51 (3), 878-884, 2015 | 67 | 2015 |
| Molecular mechanisms of meditation V Jindal, S Gupta, R Das Molecular neurobiology 48, 808-811, 2013 | 67 | 2013 |
| Glaucoma: an extension of various chronic neurodegenerative disorders V Jindal Molecular neurobiology 48, 186-189, 2013 | 51 | 2013 |
| Challenges and prospects of chimeric antigen receptor T cell therapy in solid tumors V Jindal, E Arora, S Gupta Medical Oncology 35, 1-9, 2018 | 45 | 2018 |
| Facing COVID-19 in the hematopoietic cell transplant setting: A new challenge for transplantation physicians KK Sahu, V Jindal, AD Siddiqui, J Cerny Blood Cells, Molecules & Diseases 83, 102439, 2020 | 37 | 2020 |
| Managing COVID-19 in patients with cancer: a double blow for oncologists KK Sahu, V Jindal, AD Siddiqui JCO Oncology Practice 16 (5), 223, 2020 | 34 | 2020 |
| Role of immune checkpoint inhibitors and novel immunotherapies in uveal melanoma V Jindal Chinese Clinical Oncology 7 (1), 8-8, 2018 | 34 | 2018 |
| Fungal infections in hematopoietic stem-cell transplant patients: a review of epidemiology, diagnosis, and management MS Rahi, V Jindal, P Pednekar, J Parekh, K Gunasekaran, S Sharma, ... Therapeutic Advances in Infectious Disease 8, 20499361211039050, 2021 | 33 | 2021 |
| Anti PD-1 immunotherapy related interstitial lung disease presenting as respiratory failure-A review with case series P Akella, S Loganathan, V Jindal, J Akhtar, A Lal Respiratory medicine case reports 26, 17-22, 2019 | 28 | 2019 |
| Expected paradigm shift in brain metastases therapy—immune checkpoint inhibitors V Jindal, S Gupta Molecular neurobiology 55, 7072-7078, 2018 | 28 | 2018 |
| Role of immune checkpoint inhibitors in advanced or recurrent endometrial cancer E Arora, M Masab, P Mittar, V Jindal, S Gupta, C Dourado Cureus 10 (4), 2018 | 25 | 2018 |
| Convalescent plasma therapy: A passive therapy for an aggressive COVID‐19 KK Sahu, V Jindal, AD Siddiqui, J Cerny, JM Gerber Journal of medical virology 92 (11), 2251, 2020 | 24 | 2020 |
| Prospects of chimeric antigen receptor T cell therapy in ovarian cancer V Jindal, E Arora, S Gupta, A Lal, M Masab, R Potdar Medical Oncology 35, 1-8, 2018 | 22 | 2018 |
| Rare cause of respiratory failure: a twist in the tale A Lal, J Akhtar, V Jindal, A Ullah Annals of the American Thoracic Society 15 (7), 880-883, 2018 | 21 | 2018 |
| Development and validation of a nomogram for early detection of malignant gallbladder lesions M Chen, J Cao, Y Bai, C Tong, J Lin, V Jindal, LC Barchi, S Nadalin, ... Clinical and translational gastroenterology 10 (10), e00098, 2019 | 19 | 2019 |
| Immunotherapy: a glimmer of hope for metastatic prostate cancer V Jindal Chinese Clinical Oncology 7 (6), 61-61, 2018 | 18 | 2018 |
| Current perspectives on diagnostic assays and anti-PF4 antibodies for the diagnosis of heparin-induced thrombocytopenia KK Sahu, V Jindal, J Anderson, AD Siddiqui, IA Jaiyesimi Journal of Blood Medicine, 267-277, 2020 | 16 | 2020 |
